Related Experiment Video
Updated: Jul 6, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Case Report: Severe hypertriglyceridaemia and multivessel coronary artery disease - management and plaque
Baiba Kokina1,2, Maris Lapsovs2,3, Rudolfs Roze2,3
1Department of Residency, Riga Stradins University, Riga, Latvia.
Insights
Severe hypertriglyceridaemia can occur without lipid-rich plaques. This case highlights a patient with familial hypertriglyceridaemia and low plaque lipid content, managed effectively with insulin, heparin, and plasmapheresis.
Area of Science:
- Cardiology
- Biochemistry
- Genetics
Background:
- Elevated triglycerides are a cardiovascular risk marker.
- Literature suggests a link between high triglycerides and lipid-rich plaques.
- This case presents severe hypertriglyceridaemia without lipid-rich atherosclerotic lesions.
Background:
Elevated triglycerides have been established as a cardiovascular risk marker and the literature suggests an association with lipid-rich plaques. We report a case of severe hypertriglyceridaemia that did not result in lipid-rich atherosclerotic lesions.
Case Summary:
Coronary angiography of a 54-year-old man with a triglyceride level >113.00 mmol/L revealed severe multivessel disease. Near-infrared spectroscopy (NIRS) demonstrated a low plaque lipid content, including the maximum lipid-core burden index within 4 mm of 0 in the right coronary artery (RCA), with >90% stenosis in the middle segment. To achieve a rapid reduction in the triglyceride level, intravenous administration of insulin and heparin combined with subsequent plasmapheresis was used, and a triglyceride level of 5.79 mmol/L was achieved before discharge. Genetic testing confirmed familial hypertriglyceridaemia with a pathogenic variant in the lipoprotein lipase gene.
Conclusions:
In a patient with severely elevated serum triglycerides and premature three-artery disease, low plaque lipid content was established with the NIRS investigation. Pharmacological management of very severe hypertriglyceridaemia with intravenous insulin and heparin therapy can rapidly decrease triglyceride levels.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
Atherosclerosis III: Management
